Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Implantica wins FDA approval for RefluxStop GERD implant, targeting 78 million U.S. patients
Medical device, gastrointestinal, regulatory, commercial expansion - Read more

Johnson & Johnson's Imaavy (nipocalimab) gains FDA label expansion for warm autoimmune hemolytic anemia backed by Ph2/3 data
Antibody, autoimmune, monoclonal antibody, warm autoimmune hemolytic anemia, FcRn blocker, IgG autoantibodies - Read more

GSK's Hibsago (bepirovirsen) wins Japan approval for chronic hepatitis B following Ph3 functional cure results
Antisense oligonucleotide, infectious disease, hepatitis B, HBsAg target, functional cure - Read more

Biocon Biologics' (pegfilgrastim) biosimilar wins Japan MHLW marketing approval for neutropenia supportive care
Protein therapy, cancer, biosimilar, pegfilgrastim, G-CSF, chemotherapy-induced neutropenia - Read more

Lundbeck, Eversana expand AI commercialization partnership across U.S. marketing, medical communications and market access
Commercial partnership, AI/ML, digital health, neurology, commercialization - Read more

Liminatus Pharma engages Synex as CRO for Phase 1/2a CD19xCD22 CAR-T clinical development in South Korea
CRO engagement, oncology, cell therapy, milestone payments, hematologic malignancies - Read more

AGC Inc., Neusignal Therapeutics collaborate on Alzheimer's drug candidate NTX-083, targeting 2026 U.S. clinical trials
Manufacturing agreement, small molecule, neurological, CDMO, drug discovery - Read more

Ready to supercharge your marketing AND sales workflows into biopharma?

You won’t want to miss this webinar, where Kimo (Hapatune) and Anis (Science 2 Sales) get into the nitty-gritty of both:

• Audience segmentation (how tailored marketing content can more effectively engage a focused bioprocess customer segment) and
• Cold calling (the technical underpinning and strategies + mindset to win at it)

Join us August 26th - register for free here!

Bausch + Lomb advances (lifitegrast/perfluorohexyloctane) combination eye drop to Ph3 for dry eye disease despite Ph2 primary endpoint miss
Small molecule, ophthalmology, dry eye disease, combination therapy, lifitegrast, perfluorohexyloctane - Read more

AC Immune reports positive Ph1 data for (ACI-19764), oral NLRP3 inhibitor targeting chronic inflammatory disorders
Small molecule, metabolic, NLRP3 inhibitor, cardiovascular, neurological, inflammation - Read more

Haisco Pharmaceutical Group forms Sentivera with Population Health Partners, ARCH Venture Partners for $1.5B immunology deal
Joint venture, autoimmune, small molecule, milestone payments, royalties, equity investment - Read more

Hansa Biopharma files for potential Nasdaq IPO ahead of FDA kidney transplant drug decision
Transplant medicine, antibody, rare disease, clinical-stage - Read more

McKesson to acquire Precision Medicine Group for $2.25B, expanding oncology drug development and commercialization services
Oncology, contract research organization, major transaction, strategic - Read more

Valerio Therapeutics to acquire Etherna Immunotherapies for €30M ($35.05M), raising €40.25M ($47.02M) PIPE to build targeted RNA platform
mRNA therapy, oncology, major transaction, strategic, financial - Read more

Eli Lilly launches oral obesity pill Foundayo in UK, challenging Novo Nordisk's head-start Wegovy pill
Small molecule, obesity, competitive, revenue impact - Read more

FDA grants Capricor Therapeutics three-month extension to review (deramiocel) Ph3 data for Duchenne muscular dystrophy upper limb indication
Cell therapy, neuromuscular disease, Duchenne muscular dystrophy, deramiocel, upper limb function, cardiomyopathy - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Merck & Co. and AstraZeneca lose court battles challenging Medicare drug price negotiation program
Drug pricing, Medicare, regulatory, financial - Read more

MassBio reports Massachusetts biotech venture funding surged 25% in 2026, but young startups lag behind
Biotech ecosystem, venture capital, financial, competitive - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here